Momelotinib Dihydrochloride Monohydrate is the monohydrate dihydrochloride salt form of momelotinib, an orally bioavailable small molecule inhibitor of wild-type (WT) Janus kinases 1 and 2 (JAK1/2), the JAK2 mutant form JAK2V617F, and activin A receptor type 1 (ACVR1; activin receptor like kinase 2; ALK2), with antineoplastic activity. It is grouped under the following drug class(es): Antineoplastic agents and JAK inhibitors. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Momelotinib Hydrochloride Hydrate. Its PubChem CID is 102514733.
Momelotinib dihydrochloride monohydrate
| CAS No | 1841094-17-4 |
|---|---|
| Molecular Formula | C23H26Cl2N6O3 |
| Molecular Weight | 505.4 g/mol |
| Synonyms | N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide;hydrate;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Momelotinib Dihydrochloride Monohydrate is the monohydrate dihydrochloride salt form of momelotinib, an orally bioavailable small molecule inhibitor of wild-type (WT) Janus kinases 1 and 2 (JAK1/2), the JAK2 mutant form JAK2V617F, and activin A receptor type 1 (ACVR1; activin receptor like kinase 2; ALK2), with antineoplastic activity.
The listed CAS number is 1841094-17-4.
The listed molecular formula is C23H26Cl2N6O3.
The listed molecular weight is 505.4 g/mol.
N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide;hydrate;dihydrochloride.
The source lists Momelotinib Hydrochloride Hydrate.